Newmars Technologies Ltd. products

Cervical Cancer is the 2^nd most common cancer afflicting women worldwide ^[1]. In many countries, cervical cancer screening programs utilize a Pap test. If the Pap result is abnormal a visual examination called colposcopy, and in many instances one or more biopsies of the cervix is preformed to detect abnormal cervical tissue. Recently, physicians have started to include a Human papillomavirus (HPV) DNA test in the process in order to determine if a patient has an active infection. Though these tests has proven effective in reducing the number of women dying worldwide from cervical cancer, these tests refer a high percentage of women onto unnecessary tests and procedures and in some case misses the pre-cancerous tissue entirely^12,3,4,51.